Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Number of new cancer pharmaceuticals approved by the European Medicines Agency (EMA) in Norway from 2014 to 2017
Number of new cancer pharmaceuticals approved by EMA in Norway 2014-2017
This statistic shows the number of new cancer pharmaceuticals approved by EMA (European Medicines Agency) in Norway from 2014 to 2017. The number peaked in 2015, with eight new approved cancer pharmaceuticals. In 2017, one new cancer pharmaceutical approved by EMA was on the pharmaceutical market in Norway.
Number of new cancer pharmaceuticals approved by the European Medicines Agency (EMA) in Norway from 2014 to 2017
Number of pharmaceuticals
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

November 2017

Region

Norway

Survey time period

2014 to 2017

Number of new cancer pharmaceuticals approved by EMA in Norway 2014-2017
This statistic shows the number of new cancer pharmaceuticals approved by EMA (European Medicines Agency) in Norway from 2014 to 2017. The number peaked in 2015, with eight new approved cancer pharmaceuticals. In 2017, one new cancer pharmaceutical approved by EMA was on the pharmaceutical market in Norway.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Pharmaceutical industry in Norway "
  • Overview
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
The most important statistics
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.